wr 1065 has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazek, ER; Drab-Weiss, EA; Hansra, IK; Rubin, DB | 1 |
| Drab-Weiss, EA; Mooteri, SN; Onoda, JM; Podolski, JL; Rubin, DB; Saclarides, TJ | 1 |
2 other study(ies) available for wr 1065 and Sepsis
| Article | Year |
|---|---|
Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide.
Topics: Animals; Apoptosis; Cattle; Cell Division; DNA; DNA Damage; Endothelium, Vascular; In Vitro Techniques; Lipopolysaccharides; Male; Mercaptoethylamines; Sepsis | 1998 |
Aminothiol WR-1065 protects endothelial cell morphology against alterations induced by lipopolysaccharide.
Topics: Actins; Animals; Cattle; Cells, Cultured; Cytoskeleton; Endothelium, Vascular; Humans; Integrins; Lipopolysaccharides; Mercaptoethylamines; Radiation-Protective Agents; Sepsis | 1998 |